Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 262
Gene Symbol: AMD1
AMD1
0.100 Biomarker disease BEFREE These bases contained images affected by different abnormalities, for example, diabetes, retinitis pigmentosa, and age-related macular degeneration AMD. 31444623 2020
Entrez Id: 262
Gene Symbol: AMD1
AMD1
0.100 Biomarker disease BEFREE PU-91 drug rescues human age-related macular degeneration RPE cells; implications for AMD therapeutics. 31477635 2019
Entrez Id: 262
Gene Symbol: AMD1
AMD1
0.100 Biomarker disease BEFREE The mean outer diameter was greater in the group with degenerative LMH with concomitant AMD than in the control group of degenerative LMH without AMD (1,323.9 ± 999.1 µm vs. 905.9 ± 356.8 µm, respectively; P = 0.01). 31145390 2019
Entrez Id: 262
Gene Symbol: AMD1
AMD1
0.100 Biomarker disease BEFREE We found 28 eyes showed neovascular AMD (nvAMD), and 17 had nonneovascular (dry) AMD (dAMD). 31348823 2019
Entrez Id: 262
Gene Symbol: AMD1
AMD1
0.100 GeneticVariation disease BEFREE Importantly, mLOY was associated with late-stage AMD with genome-wide significance (OR: 1.332 [95% CI: 1.206; 1.472], P = 1.60e-08), independent of age, the AMD genetic risk score and the first two principle components of ancestry. 30158665 2019
Entrez Id: 262
Gene Symbol: AMD1
AMD1
0.100 Biomarker disease BEFREE To investigate the association of treatment assignment (intravitreal aflibercept vs ranibizumab) and baseline characteristics with fellow eye conversion to nAMD in the VEGF (Vascular Endothelial Growth Factor) Trap-Eye: Investigation of Efficacy and Safety in Wet AMD (VIEW) studies. 31294771 2019
Entrez Id: 262
Gene Symbol: AMD1
AMD1
0.100 Biomarker disease BEFREE The onset of neurodegenerative diseases activates inflammation that leads to progressive neuronal cell death and impairments in cognition (Alzheimer's disease) and sight (age-related macular degeneration [AMD]). 31712409 2019
Entrez Id: 262
Gene Symbol: AMD1
AMD1
0.100 Biomarker disease BEFREE Patients with geographic atrophy (GA) secondary to AMD were recruited in the context of the Longitudinal Fundus Autofluorescence in Age-related Macular Degeneration and Directional Spread in Geographic Atrophy studies (NCT00393692, NCT02051998). 29558533 2018
Entrez Id: 262
Gene Symbol: AMD1
AMD1
0.100 Biomarker disease BEFREE Strong experimental evidence from studies of human donors with AMD supports the emerging hypothesis that defects in RPE mitochondria drive AMD pathology. 30025108 2018
Entrez Id: 262
Gene Symbol: AMD1
AMD1
0.100 Biomarker disease BEFREE The NORMAL-1 and NORMAL-2 datasets contain healthy OCT B-scans while the AMD-1 and DME-1 dataset contain B-scans of AMD and DME cases respectively. 30337078 2018
Entrez Id: 262
Gene Symbol: AMD1
AMD1
0.100 Biomarker disease BEFREE Incidence of early AMD was associated with early AMD in the fellow eye (early AMD1: HR, 2.6; 95% CI, 1.6-4.2; early AMD2: HR, 5.6; 95% CI, 3.3-9.4) and high plasma high-density lipoprotein cholesterol levels (HR, 1.2; 95% CI, 1.0-1.4). 29596588 2018
Entrez Id: 262
Gene Symbol: AMD1
AMD1
0.100 Biomarker disease BEFREE The Beaver Dam study and the Pathologies Oculaires Liées à L'âge study both noted that wearing hats and/or sunglasses significantly decrease some AMD lesions, suggesting that reduced retinal light dose (RLD) may be related to reduced AMD risk. 30073359 2018
Entrez Id: 262
Gene Symbol: AMD1
AMD1
0.100 GeneticVariation disease BEFREE EFEMP1 (fibulin-3) is mutated in Malattia Leventinese/Doyne's honeycomb retinal dystrophy (ML/DHRD), an inherited macular dystrophy similar to AMD. 28264101 2017
Entrez Id: 262
Gene Symbol: AMD1
AMD1
0.100 GeneticVariation disease BEFREE To examine the most frequent outcomes used in trials and reviews of the 4 most prevalent eye diseases (age-related macular degeneration [AMD], cataract, diabetic retinopathy [DR], and glaucoma) and the overlap between outcomes in the reviews and the trials included in the reviews. 28772305 2017
Entrez Id: 262
Gene Symbol: AMD1
AMD1
0.100 Biomarker disease BEFREE 140 patients (mean age 78) participated in the awareness survey; 62.1% reported being 'aware' of AMD but only 37.3% described AMD symptoms correctly. 29229653 2017
Entrez Id: 262
Gene Symbol: AMD1
AMD1
0.100 GeneticVariation disease BEFREE The age-related maculopathy susceptibility2 (ARMS2)/LOC387715 rs10490924" genes_norm="387715">A69S (rs10490924) polymorphism and cigarette smoking have been shown to have significant association with AMD. 28095100 2017
Entrez Id: 262
Gene Symbol: AMD1
AMD1
0.100 GeneticVariation disease BEFREE We found an increased long-term mortality in individuals with wet AMD treated with bevacizumab compared to a same age and gender group without wet AMD. 29017506 2017
Entrez Id: 262
Gene Symbol: AMD1
AMD1
0.100 GeneticVariation disease BEFREE Advances in translating AMD genetics findings for AMD risk prediction require development of a genetics-based causality for AMD incidence and progression. 25125423 2014
Entrez Id: 262
Gene Symbol: AMD1
AMD1
0.100 GeneticVariation disease BEFREE Protection against AMD from greater LZ and fish consumption in persons with high genetic risk based on 2 major AMD genes raises the possibility of personalized preventive interventions. 24290803 2014
Entrez Id: 262
Gene Symbol: AMD1
AMD1
0.100 GeneticVariation disease BEFREE This study attempted to find novel age-related macular degeneration (AMD) related genes based on 36 known AMD genes. 24455700 2013
Entrez Id: 262
Gene Symbol: AMD1
AMD1
0.100 GeneticVariation disease BEFREE Early AMD lesion characteristics (type, location, area involved) were strongly associated with higher long-term risk of developing GA independent of age, smoking, and AMD genetic susceptibility from the CFH or ARMS2 genes. 23706948 2013
Entrez Id: 262
Gene Symbol: AMD1
AMD1
0.100 Biomarker disease BEFREE They also show that when early AMD is present, knowing the phenotype contributes more to risk assessment than knowing the genetic risk based on these 2 AMD genes. 23494043 2013
Entrez Id: 262
Gene Symbol: AMD1
AMD1
0.100 GeneticVariation disease BEFREE Participants (247 nvAMD, 52 early age-related macular degeneration [AMD], and 103 controls) were genotyped (complement factor H and ARMS2/HTRA1). nvAMD participants were assigned to one of two subcategories: mainly classic or mainly occult (based on the proportions of classic and occult choroidal neovascularization). nvAMD and early AMD were reassigned to two groups based on the extent and severity of drusen (retinal pigment epithelium dysfunction or not). 22487577 2012
Entrez Id: 262
Gene Symbol: AMD1
AMD1
0.100 Biomarker disease BEFREE Toward the discovery of tools for early identification of AMD susceptibility, we evaluated the combined predictive capability of proteomic and genomic AMD biomarkers. 19202148 2009
Entrez Id: 262
Gene Symbol: AMD1
AMD1
0.100 Biomarker disease BEFREE This finding is consistent with the role of HTRA1 in AMD pathogenesis and will help aid in the clinical management and prognosis of AMD patients. 18206206 2008